Advertisement

Perioperative Psychiatric Problems in Organ Transplantation

  • Paula C. ZimbreanEmail author
  • Nora Proops
Chapter

Abstract

This chapter begins with a brief review of the history of organ transplantation and a description of the process of transplantation listing and postsurgical care, which are relevant to understand the patient’s journey through this complex process. We will then present the most important findings regarding prevalence of psychiatric problems in transplant candidates and recipients, followed by a review of the evidence about the impact of psychiatric presentations upon the post specific transplantation outcomes. This chapter will focus on the psychiatric implications of transplantation among recipients and donors of solid organs—specifically, the kidney, pancreas, liver, heart, lung, and intestine. The procedures involving other human tissues (such as the cornea, skin, bone marrow, and vascularized composite allographs) will not be addressed. A separate section in this chapter is dedicated to the most important psychiatric aspects of living organ donors.

Keywords

Organ transplantation Organ donation Transplant psychiatry Psychosocial risk Postsurgical outcomes Psychosocial criteria 

References

  1. 1.
    UNOS-History [cited 2018 04/03]. Available from: https://unos.org/transplantation/history/
  2. 2.
    Anatomical Gift Act. The National Conference of Commissioners on Uniform State Laws [cited 2018 04/03]. 2006. Available from: http://uniformlaws.org/Act.aspx?title=Anatomical%20Gift%20Act%20(2006)
  3. 3.
    Rao PS, Schaubel DE, Guidinger MK, Andreoni KA, Wolfe RA, Merion RM, et al. A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index. Transplantation. 2009;88(2):231–6.PubMedCrossRefGoogle Scholar
  4. 4.
    Lau T, Ahmad J. Clinical applications of the Model for End-stage Liver Disease (MELD) in hepatic medicine. Hepat Med. 2013;5:1–10.PubMedPubMedCentralGoogle Scholar
  5. 5.
    National Data. Organ Procurement and Transplantation Network. US Department of Health and Human Services [cited 2017 12/07]. 2017. Available from: https://optn.transplant.hrsa.gov/data/view-data-reports/national-data
  6. 6.
    Need Continues to Grow. Organ Procurement and Transplantation Network. US Department of Health and Human Services [cited 2018 04/03]. Available from: https://optn.transplant.hrsa.gov/need-continues-to-grow
  7. 7.
  8. 8.
    Nahum LH. Transplant psychosis. Conn Med. 1969;33(8):508 passim.PubMedGoogle Scholar
  9. 9.
    Allen JP, Wurst FM, Thon N, Litten RZ. Assessing the drinking status of liver transplant patients with alcoholic liver disease. Liver Transpl. 2013;19(4):369–76.PubMedCrossRefGoogle Scholar
  10. 10.
    Everhart JE, Beresford TP. Liver transplantation for alcoholic liver disease: a survey of transplantation programs in the United States. Liver Transpl Surg. 1997;3(3):220–6.PubMedCrossRefGoogle Scholar
  11. 11.
    Lentine KL, Lam NN, Xiao H, Tuttle-Newhall JE, Axelrod D, Brennan DC, et al. Associations of pre-transplant prescription narcotic use with clinical complications after kidney transplantation. Am J Nephrol. 2015;41(2):165–76.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Levenson JL, Olbrisch ME. Psychosocial evaluation of organ transplant candidates. A comparative survey of process, criteria, and outcomes in heart, liver, and kidney transplantation. Psychosomatics. 1993;34(4):314–23.PubMedCrossRefGoogle Scholar
  13. 13.
    Mathurin P, Moreno C, Samuel D, Dumortier J, Salleron J, Durand F, et al. Early liver transplantation for severe alcoholic hepatitis. N Engl J Med. 2011;365(19):1790–800.PubMedCrossRefGoogle Scholar
  14. 14.
    Hajifathalian K, Humberson A, Hanouneh MA, Barnes DS, Arora Z, Zein NN, et al. Ohio solid organ transplantation consortium criteria for liver transplantation in patients with alcoholic liver disease. World J Hepatol. 2016;8(27):1149–54.PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    Zimbrean P, Emre S. Patients with psychotic disorders in solid-organ transplant. Prog Transplant. 2015;25(4):289–96.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Gazdag G, Horvath GG, Makara M, Ungvari GS, Gerlei Z. Predictive value of psychosocial assessment for the mortality of patients waiting for liver transplantation. Psychol Health Med. 2016;21(4):525–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Carnrike CL Jr, McCracken LM, Aikens JE. Social desirability, perceived stress, and PACT ratings in lung transplant candidates: a preliminary investigation. J Clin Psychol Med Settings. 1996;3(1):57–67.PubMedCrossRefGoogle Scholar
  18. 18.
    Maldonado JR, Sher Y, Lolak S, Swendsen H, Skibola D, Neri E, et al. The Stanford integrated psychosocial assessment for transplantation: a prospective study of medical and psychosocial outcomes. Psychosom Med. 2015;77(9):1018–30.PubMedCrossRefGoogle Scholar
  19. 19.
    Adinolfi LE, Nevola R, Rinaldi L, Romano C, Giordano M. Chronic hepatitis C virus infection and depression. Clin Liver Dis. 2017;21(3):517–34.PubMedCrossRefGoogle Scholar
  20. 20.
    Doering LV, Chen B, Deng M, Mancini D, Kobashigawa J, Hickey K. Perceived control and health-related quality of life in heart transplant recipients. Eur J Cardiovasc Nurs. 2017;17(6):513–20.PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    Chilcot J, Hudson JL, Moss-Morris R, Carroll A, Game D, Simpson A, et al. Screening for psychological distress using the Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS): initial validation of structural validity in dialysis patients. Gen Hosp Psychiatry. 2018;50:15–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Mohamed S, Sabki ZA, Zainal NZ. Depression and psychosocial correlates of liver transplant candidates: a systematic review. Asia Pac Psychiatry. 2014;6(4):447–53.PubMedGoogle Scholar
  23. 23.
    Dew MA, Kormos RL, DiMartini AF, Switzer GE, Schulberg HC, Roth LH, et al. Prevalence and risk of depression and anxiety-related disorders during the first three years after heart transplantation. Psychosomatics. 2001;42(4):300–13.PubMedCrossRefGoogle Scholar
  24. 24.
    Anvar-Abnavi M, Bazargani Z. Prevalence of anxiety and depression in Iranian kidney transplant recipients. Neurosciences. 2010;15(4):254–7.PubMedGoogle Scholar
  25. 25.
    Annema C, Roodbol PF, Stewart RE, Porte RJ, Ranchor AV. Prevalence of psychological problems and associated transplant-related variables at different time periods after liver transplantation. Liver Transpl. 2015;21(4):524–38.PubMedCrossRefGoogle Scholar
  26. 26.
    Sirri L, Potena L, Masetti M, Tossani E, Grigioni F, Magelli C, et al. Prevalence of substance-related disorders in heart transplantation candidates. Transplant Proc. 2007;39(6):1970–2.PubMedCrossRefGoogle Scholar
  27. 27.
    Evans LD, Stock EM, Zeber JE, Morissette SB, MacCarthy AA, Sako EY, et al. Posttransplantation outcomes in veterans with serious mental illness. Transplantation. 2015;99(8):e57–65.PubMedCrossRefGoogle Scholar
  28. 28.
    Webzell I, Ball D, Bell J, Sherwood RA, Marsh A, O’Grady JG, et al. Substance use by liver transplant candidates: an anonymous urinalysis study. Liver Transpl. 2011;17(10):1200–4.PubMedCrossRefGoogle Scholar
  29. 29.
    Osthus TB, Preljevic V, Sandvik L, Dammen T, Os I. Renal transplant acceptance status, health-related quality of life and depression in dialysis patients. J Ren Care. 2012;38(2):98–106.PubMedCrossRefGoogle Scholar
  30. 30.
    Craven J. Psychiatric aspects of lung transplant. The Toronto Lung Transplant Group. Can J Psychiatr. 1990;35(9):759–64.CrossRefGoogle Scholar
  31. 31.
    Cheng Y, Zhang G, Shen W, Huang LX, Zhang L, Xie SS, et al. Impact of previous episodes of hepatic encephalopathy on short-term brain function recovery after liver transplantation: a functional connectivity strength study. Metab Brain Dis. 2018;33(1):237–49.PubMedCrossRefGoogle Scholar
  32. 32.
    van Zwieten A, Wong G, Ruospo M, Palmer SC, Barulli MR, Iurillo A, et al. Prevalence and patterns of cognitive impairment in adult hemodialysis patients: the COGNITIVE-HD study. Nephrol Dial Transplant. 2017;33(7):1197–206.CrossRefGoogle Scholar
  33. 33.
    Burkhalter H, Denhaerynck K, Huynh-Do U, Binet I, Hadaya K, De Geest S. Change of sleep quality from pre- to 3 years post-solid organ transplantation: the Swiss Transplant Cohort Study. PLoS One. 2017;12(10):e0185036.PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    Adams RJ, Appleton SL, Vakulin A, Hanly PJ, McDonald SP, Martin SA, et al. Chronic kidney disease and sleep apnea association of kidney disease with obstructive sleep apnea in a population study of men. Sleep. 2017;40(1)  https://doi.org/10.1093/sleep/zsw015.
  35. 35.
    Lin Z, Zhao C, Luo Q, Xia X, Yu X, Huang F. Prevalence of restless legs syndrome in chronic kidney disease: a systematic review and meta-analysis of observational studies. Ren Fail. 2016;38(9):1335–46.PubMedCrossRefGoogle Scholar
  36. 36.
    Stilley CS, Dew MA, Pilkonis P, Bender A, McNulty M, Christensen A, et al. Personality characteristics among cardiothoracic transplant recipients. Gen Hosp Psychiatry. 2005;27(2):113–8.PubMedCrossRefGoogle Scholar
  37. 37.
    Oliver N, Bohorquez H, Anders S, Freeman A, Fine K, Ahmed E, et al. Post-liver transplant delirium increases mortality and length of stay. Ochsner J. 2017;17(1):25–30.PubMedPubMedCentralGoogle Scholar
  38. 38.
    Lee J, Kim DK, Lee JW, Oh KH, Oh YK, Na KY, et al. Rapid correction rate of hyponatremia as an independent risk factor for neurological complication following liver transplantation. Tohoku J Exp Med. 2013;229(2):97–105.PubMedCrossRefGoogle Scholar
  39. 39.
    Smith PJ, Rivelli SK, Waters AM, Hoyle A, Durheim MT, Reynolds JM, et al. Delirium affects length of hospital stay after lung transplantation. J Crit Care. 2015;30(1):126–9.PubMedCrossRefGoogle Scholar
  40. 40.
    Flynn K, Daiches A, Malpus Z, Yonan N, Sanchez M. “A post-transplant person”: narratives of heart or lung transplantation and intensive care unit delirium. Health (London). 2014;18(4):352–68.CrossRefGoogle Scholar
  41. 41.
    Van Sandwijk MS, Ten Berge IJ, Majoie CB, Caan MW, De Sonneville LM, Van Gool WA, et al. Cognitive changes in chronic kidney disease and after transplantation. Transplantation. 2016;100(4):734–42.PubMedCrossRefGoogle Scholar
  42. 42.
    Zimbrean P, Crone C, Sher Y, Dew MA, DiMartini A. Transplant psychiatry: psychiatric care of organ donors and recipients. Psychiatr Times. 2016;33: 24F–24H.Google Scholar
  43. 43.
    Brown ES, Chandler PA. Mood and cognitive changes during systemic corticosteroid therapy. Prim Care Companion J Clin Psychiatry. 2001;3(1):17–21.PubMedPubMedCentralCrossRefGoogle Scholar
  44. 44.
    Fardet L, Petersen I, Nazareth I. Suicidal behavior and severe neuropsychiatric disorders following glucocorticoid therapy in primary care. Am J Psychiatry. 2012;169(5):491–7.PubMedCrossRefGoogle Scholar
  45. 45.
    Bolanos SH, Khan DA, Hanczyc M, Bauer MS, Dhanani N, Brown ES. Assessment of mood states in patients receiving long-term corticosteroid therapy and in controls with patient-rated and clinician-rated scales. Ann Allergy Asthma Immunol. 2004;92(5):500–5.PubMedCrossRefGoogle Scholar
  46. 46.
    Keenan PA, Jacobson MW, Soleymani RM, Mayes MD, Stress ME, Yaldoo DT. The effect on memory of chronic prednisone treatment in patients with systemic disease. Neurology. 1996;47(6):1396–402.PubMedCrossRefGoogle Scholar
  47. 47.
    Davis JM, Leach A, Merk B, Janicak PG. Treatment of steroid psychoses. Psychiatr Ann. 1992;22(9):487–91.CrossRefGoogle Scholar
  48. 48.
    Bhat M, Wyse JM, Moodie E, Ghali P, Hilzenrat N, Wong P, et al. Prevalence and predictors of sleep disturbance among liver diseases in long-term transplant survivors. Can J Gastroenterol Hepatol. 2015;29(8):440–4.PubMedPubMedCentralCrossRefGoogle Scholar
  49. 49.
    Brekke FB, Waldum-Grevbo B, von der Lippe N, Os I. The effect of renal transplantation on quality of sleep in former dialysis patients. Transpl Int. 2017;30(1):49–56.PubMedCrossRefGoogle Scholar
  50. 50.
    Sommerwerck U, Kleibrink BE, Kruse F, Scherer MJ, Wang Y, Kamler M, et al. Predictors of obstructive sleep apnea in lung transplant recipients. Sleep Med. 2016;21:121–5.PubMedCrossRefGoogle Scholar
  51. 51.
    Dew MA, DiMartini AF, DeVito Dabbs AJ, Fox KR, Myaskovsky L, Posluszny DM, et al. Onset and risk factors for anxiety and depression during the first 2 years after lung transplantation. Gen Hosp Psychiatry. 2012;34(2):127–38.PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Davydow DS, Lease ED, Reyes JD. Posttraumatic stress disorder in organ transplant recipients: a systematic review. Gen Hosp Psychiatry. 2015;37(5):387–98.PubMedPubMedCentralCrossRefGoogle Scholar
  53. 53.
    Spivey CA, Chisholm-Burns MA, Damadzadeh B, Billheimer D. Determining the effect of immunosuppressant adherence on graft failure risk among renal transplant recipients. Clin Transpl. 2014;28(1):96–104.CrossRefGoogle Scholar
  54. 54.
    Lieber SR, Volk ML. Non-adherence and graft failure in adult liver transplant recipients. Dig Dis Sci. 2013;58(3):824–34.PubMedCrossRefGoogle Scholar
  55. 55.
    Taber DJ, Fleming JN, Fominaya CE, Gebregziabher M, Hunt KJ, Srinivas TR, et al. The impact of health care appointment non-adherence on graft outcomes in kidney transplantation. Am J Nephrol. 2017;45(1):91–8.PubMedCrossRefGoogle Scholar
  56. 56.
    Brocks Y, Zittermann A, Grisse D, Schmid-Ott G, Stock-Giessendanner S, Schulz U, et al. Adherence of heart transplant recipients to prescribed medication and recommended lifestyle habits. Prog Transplant. 2017;27(2):160–6.PubMedCrossRefGoogle Scholar
  57. 57.
    Scheel JF, Schieber K, Reber S, Stoessel L, Waldmann E, Jank S, et al. Psychosocial variables associated with immunosuppressive medication non-adherence after renal transplantation. Front Psych. 2018;9:23.CrossRefGoogle Scholar
  58. 58.
    Belaiche S, Decaudin B, Dharancy S, Noel C, Odou P, Hazzan M. Factors relevant to medication non-adherence in kidney transplant: a systematic review. Int J Clin Pharm. 2017;39(3):582–93.PubMedCrossRefGoogle Scholar
  59. 59.
    Duncan S, Annunziato RA, Dunphy C, LaPointe RD, Shneider BL, Shemesh E. A systematic review of immunosuppressant adherence interventions in transplant recipients: decoding the streetlight effect. Pediatr Transplant. 2018;22(1)  https://doi.org/10.1111/petr.13086.CrossRefGoogle Scholar
  60. 60.
    Constantiner M, Rosenthal-Asher D, Tedla F, Salifu M, Cukor J, Wyka K, et al. Differences in attitudes toward immunosuppressant therapy in a multi-ethnic sample of kidney transplant recipients. J Clin Psychol Med Settings. 2017;25(1):11–9.CrossRefGoogle Scholar
  61. 61.
    Szeifert L, Molnar MZ, Ambrus C, Koczy AB, Kovacs AZ, Vamos EP, et al. Symptoms of depression in kidney transplant recipients: a cross-sectional study. Am J Kidney Dis. 2010;55(1):132–40.PubMedCrossRefGoogle Scholar
  62. 62.
    Muller HH, Englbrecht M, Wiesener MS, Titze S, Heller K, Groemer TW, et al. Depression, anxiety, resilience and coping pre and post kidney transplantation – initial findings from the Psychiatric Impairments in Kidney Transplantation (PI-KT)-Study. PLoS One. 2015;10(11):e0140706.PubMedPubMedCentralCrossRefGoogle Scholar
  63. 63.
    Smith PJ, Rivelli S, Waters A, Reynolds J, Hoyle A, Flowers M, et al. Neurocognitive changes after lung transplantation. Ann Am Thorac Soc. 2014;11(10):1520–7.PubMedPubMedCentralCrossRefGoogle Scholar
  64. 64.
    Dixon BS, VanBuren JM, Rodrigue JR, Lockridge RS, Lindsay R, Chan C, et al. Cognitive changes associated with switching to frequent nocturnal hemodialysis or renal transplantation. BMC Nephrol. 2016;17:12.PubMedPubMedCentralCrossRefGoogle Scholar
  65. 65.
    Dew MA, DiMartini AF. Psychological disorders and distress after adult cardiothoracic transplantation. J Cardiovasc Nurs. 2005;20(5 Suppl):S51–66.PubMedCrossRefGoogle Scholar
  66. 66.
    Martinelli V, Fusar-Poli P, Emanuele E, Klersy C, Campana C, Barale F, et al. Getting old with a new heart: impact of age on depression and quality of life in long-term heart transplant recipients. J Heart Lung Transplant. 2007;26(5):544–8.PubMedCrossRefGoogle Scholar
  67. 67.
    Dew MA, DiMartini AF, Steel J, De Vito DA, Myaskovsky L, Unruh M, et al. Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs. Liver Transpl. 2008;14(2):159–72.PubMedPubMedCentralCrossRefGoogle Scholar
  68. 68.
    Dumortier J, Dharancy S, Cannesson A, Lassailly G, Rolland B, Pruvot FR, et al. Recurrent alcoholic cirrhosis in severe alcoholic relapse after liver transplantation: a frequent and serious complication. Am J Gastroenterol. 2015;110(8):1160–6. quiz 7.CrossRefGoogle Scholar
  69. 69.
    Baguelin-Pinaud A, Moinier D, Fouldrin G, Le Roy F, Etienne I, Godin M, et al. Renal transplantation, anxiety and depressive disorders and quality of life. Encéphale. 2009;35(5):429–35.PubMedCrossRefGoogle Scholar
  70. 70.
    Baranyi A, Krauseneck T, Rothenhausler HB. Overall mental distress and health-related quality of life after solid-organ transplantation: results from a retrospective follow-up study. Health Qual Life Outcomes. 2013;11:15.PubMedPubMedCentralCrossRefGoogle Scholar
  71. 71.
    Burkhalter H, Wirz-Justice A, Cajochen C, Weaver TE, Steiger J, Fehr T, et al. Daytime sleepiness in renal transplant recipients is associated with immunosuppressive non-adherence: a cross-sectional, multi-center study. Clin Transpl. 2014;28(1):58–66.CrossRefGoogle Scholar
  72. 72.
    Calia R, Lai C, Aceto P, Luciani M, Saraceni C, Avolio AW, et al. Psychological risk factors for graft rejection among liver transplant recipients. Transplant Proc. 2011;43(4):1123–7.PubMedCrossRefGoogle Scholar
  73. 73.
    Chacko RC, Harper RG, Gotto J, Young J. Psychiatric interview and psychometric predictors of cardiac transplant survival. Am J Psychiatry. 1996;153(12):1607–12.PubMedCrossRefGoogle Scholar
  74. 74.
    Corruble E, Barry C, Varescon I, Falissard B, Castaing D, Samuel D. Depressive symptoms predict long-term mortality after liver transplantation. J Psychosom Res. 2011;71(1):32–7.PubMedCrossRefGoogle Scholar
  75. 75.
    Cukor D, Rosenthal DS, Jindal RM, Brown CD, Kimmel PL. Depression is an important contributor to low medication adherence in hemodialyzed patients and transplant recipients. Kidney Int. 2009;75(11):1223–9.CrossRefGoogle Scholar
  76. 76.
    Dobbels F, Skeans MA, Snyder JJ, Tuomari AV, Maclean JR, Kasiske BL. Depressive disorder in renal transplantation: an analysis of Medicare claims. Am J Kidney Dis. 2008;51(5):819–28.PubMedCrossRefGoogle Scholar
  77. 77.
    Dobbels F, Vanhaecke J, Dupont L, Nevens F, Verleden G, Pirenne J, et al. Pretransplant predictors of posttransplant adherence and clinical outcome: an evidence base for pretransplant psychosocial screening. Transplantation. 2009;87(10):1497–504.PubMedCrossRefGoogle Scholar
  78. 78.
    Errichiello L, Picozzi D, de Notaris EB. Prevalence of psychiatric disorders and suicidal ideation in liver transplanted patients: a cross-sectional study. Clin Res Hepatol Gastroenterol. 2014;38(1):55–62.PubMedCrossRefGoogle Scholar
  79. 79.
    Favaro A, Gerosa G, Caforio AL, Volpe B, Rupolo G, Zarneri D, et al. Posttraumatic stress disorder and depression in heart transplantation recipients: the relationship with outcome and adherence to medical treatment. Gen Hosp Psychiatry. 2011;33(1):1–7.PubMedCrossRefGoogle Scholar
  80. 80.
    Grat M, Lewandowski Z, Grat K, Wronka KM, Krasnodebski M, Barski K, et al. Negative outcomes after liver transplantation in patients with alcoholic liver disease beyond the fifth post-transplant year. Clin Transpl. 2014;28(10):1112–20.CrossRefGoogle Scholar
  81. 81.
    Guimaro MS, Lacerda SS, Aguilar MR, Karam CH, Kernkraut AM, Ferraz-Neto BH. Post-traumatic stress disorders, mood disorders, and quality of life in transplant recipients with acute liver failure. Transplant Proc. 2011;43(1):187–8.PubMedCrossRefGoogle Scholar
  82. 82.
    Havik OE, Sivertsen B, Relbo A, Hellesvik M, Grov I, Geiran O, et al. Depressive symptoms and all-cause mortality after heart transplantation. Transplantation. 2007;84(1):97–103.PubMedCrossRefGoogle Scholar
  83. 83.
    Jin SG, Yan LN, Xiang B, Li B, Wen TF, Zhao JC, et al. Posttraumatic stress disorder after liver transplantation. Hepatobiliary Pancreat Dis Int. 2012;11(1):28–33.PubMedCrossRefGoogle Scholar
  84. 84.
    Jindal RM, Neff RT, Abbott KC, Hurst FP, Elster EA, Falta EM, et al. Association between depression and nonadherence in recipients of kidney transplants: analysis of the United States renal data system. Transplant Proc. 2009;41(9):3662–6.PubMedCrossRefGoogle Scholar
  85. 85.
    Jowsey SG, Cutshall SM, Colligan RC, Stevens SR, Kremers WK, Vasquez AR, et al. Seligman’s theory of attributional style: optimism, pessimism, and quality of life after heart transplant. Prog Transplant. 2012;22(1):49–55.PubMedCrossRefGoogle Scholar
  86. 86.
    Snipelisky D, Stulak JM, Schettle SD, Sharma S, Kushwaha SS, Dunlay SM. Psychosocial characteristics and outcomes in patients with left ventricular assist device implanted as destination therapy. Am Heart J. 2015;170(5):887–94.PubMedPubMedCentralCrossRefGoogle Scholar
  87. 87.
    Kugler C, Bara C, von Waldthausen T, Einhorn I, Haastert B, Fegbeutel C, et al. Association of depression symptoms with quality of life and chronic artery vasculopathy: a cross-sectional study in heart transplant patients. J Psychosom Res. 2014;77(2):128–34.PubMedCrossRefGoogle Scholar
  88. 88.
    Kusleikaite N, Bumblyte IA, Pakalnyte R. Quality of life and depression in renal transplant patients. [Lithuanian]. Medicina (Kaunas, Lithuania). 2007;43(Suppl 1):103–8.Google Scholar
  89. 89.
    Lamba S, Nagurka R, Desai KK, Chun SJ, Holland B, Koneru B. Self-reported non-adherence to immune-suppressant therapy in liver transplant recipients: demographic, interpersonal, and intrapersonal factors. Clin Transpl. 2012;26(2):328–35.CrossRefGoogle Scholar
  90. 90.
    Madan A, White-Williams C, Borckardt JJ, Burker EJ, Milsom VA, Pelic CM, et al. Beyond rose colored glasses: the adaptive role of depressive and anxious symptoms among individuals with heart failure who were evaluated for transplantation. Clin Transpl. 2012;26(3):E223–31.CrossRefGoogle Scholar
  91. 91.
    Novak M, Molnar MZ, Szeifert L, Kovacs AZ, Vamos EP, Zoller R, et al. Depressive symptoms and mortality in patients after kidney transplantation: a prospective prevalent cohort study. Psychosom Med. 2010;72(6):527–34.PubMedCrossRefGoogle Scholar
  92. 92.
    Owen JE, Bonds CL, Wellisch DK. Psychiatric evaluations of heart transplant candidates: predicting post-transplant hospitalizations, rejection episodes, and survival. Psychosomatics. 2006;47(3):213–22.PubMedCrossRefGoogle Scholar
  93. 93.
    Rice JP, Eickhoff J, Agni R, Ghufran A, Brahmbhatt R, Lucey MR. Abusive drinking after liver transplantation is associated with allograft loss and advanced allograft fibrosis. Liver Transpl. 2013;19(12):1377–86.PubMedCrossRefGoogle Scholar
  94. 94.
    Rodrigue JR, Nelson DR, Hanto DW, Reed AI, Curry MP. Patient-reported immunosuppression nonadherence 6 to 24 months after liver transplant: association with pretransplant psychosocial factors and perceptions of health status change. Prog Transplant. 2013;23(4):319–28.PubMedPubMedCentralCrossRefGoogle Scholar
  95. 95.
    Rogal SS, Landsittel D, Surman O, Chung RT, Rutherford A. Pretransplant depression, antidepressant use, and outcomes of orthotopic liver transplantation. Liver Transpl. 2011;17(3):251–60.PubMedPubMedCentralCrossRefGoogle Scholar
  96. 96.
    Rogal SS, Dew MA, Fontes P, DiMartini AF. Early treatment of depressive symptoms and long-term survival after liver transplantation. Am J Transplant. 2013;13(4):928–35.PubMedPubMedCentralCrossRefGoogle Scholar
  97. 97.
    Russell CL, Cetingok M, Hamburger KQ, Owens S, Thompson D, Hathaway D, et al. Medication adherence in older renal transplant recipients. Clin Nurs Res. 2010;19(2):95–112.PubMedCrossRefGoogle Scholar
  98. 98.
    Shapiro PA, Williams DL, Foray AT, Gelman IS, Wukich N, Sciacca R. Psychosocial evaluation and prediction of compliance problems and morbidity after heart transplantation. Transplantation. 1995;60(12):1462–6.PubMedCrossRefGoogle Scholar
  99. 99.
    Sharma NC, Kim D. The utility of psychosocial assessment tools in predicting cardiovascular outcomes in post cardiac transplant patients. J Heart Lung Transplant. 2013;1:S197.CrossRefGoogle Scholar
  100. 100.
    Sirri L, Potena L, Masetti M, Tossani E, Magelli C, Grandi S. Psychological predictors of mortality in heart transplanted patients: a prospective, 6-year follow-up study. Transplantation. 2010;89(7):879–86.PubMedCrossRefGoogle Scholar
  101. 101.
    Smith PJ, Blumenthal JA, Carney RM, Freedland KE, O’Hayer CV, Trulock EP, et al. Neurobehavioral functioning and survival following lung transplantation. Chest. 2014;145(3):604–11.PubMedCrossRefGoogle Scholar
  102. 102.
    Smith PJ, Blumenthal JA, Hoffman BM, Davis RD, Palmer SM. Postoperative cognitive dysfunction and mortality following lung transplantation. Am J Transplant. 2017;18(3):696–703.PubMedCrossRefGoogle Scholar
  103. 103.
    Smith PJ, Snyder LD, Palmer SM, Hoffman BM, Stonerock GL, Ingle KK, et al. Depression, social support, and clinical outcomes following lung transplantation: a single-center cohort study. Transpl Int. 2017;31(5):495–502.PubMedCrossRefGoogle Scholar
  104. 104.
    Spaderna H, Mendell NR, Zahn D, Wang Y, Kahn J, Smits JM, et al. Social isolation and depression predict 12-month outcomes in the “waiting for a new heart study”. J Heart Lung Transplant. 2010;29(3):247–54.PubMedCrossRefGoogle Scholar
  105. 105.
    Tsunoda T, Yamashita R, Kojima Y, Takahara S. Risk factors for depression after kidney transplantation. Transplant Proc. 2010;42(5):1679–81.PubMedCrossRefGoogle Scholar
  106. 106.
    Weng FL, Chandwani S, Kurtyka KM, Zacker C, Chisholm-Burns MA, Demissie K. Prevalence and correlates of medication non-adherence among kidney transplant recipients more than 6 months post-transplant: a cross-sectional study. BMC Nephrol. 2013;14:261.PubMedPubMedCentralCrossRefGoogle Scholar
  107. 107.
    Telles-Correia D, Barbosa A, Mega I, Monteiro E. Predictors of mental health and quality of life after liver transplantation. Psychother Psychosom. 2011;80(1):60–1.PubMedCrossRefGoogle Scholar
  108. 108.
    Fineberg SK, West A, Na PJ, Oldham M, Schilsky M, Hawkins KA, et al. Utility of pretransplant psychological measures to predict posttransplant outcomes in liver transplant patients: a systematic review. Gen Hosp Psychiatry. 2016;40:4–11.PubMedCrossRefGoogle Scholar
  109. 109.
    Fireman M, DiMartini AF, Crone CC. Organ transplantation. In: Levenson JLFS, editor. Clinical manual of psychopharmacology in the medically ill. 2nd ed. Arlington: American Psychiatric Association Publishing; 2017. p. 597–631.Google Scholar
  110. 110.
    Gross CR, Reilly-Spong M, Park T, Zhao R, Gurvich OV, Ibrahim HN. Telephone-adapted mindfulness-based stress reduction (tMBSR) for patients awaiting kidney transplantation. Contemp Clin Trials. 2017;57:37–43.PubMedPubMedCentralCrossRefGoogle Scholar
  111. 111.
    DeMartini KS, Schilsky ML, Palmer A, Fehon DC, Zimbrean P, O’Malley SS, et al. Text messaging to reduce alcohol relapse in prelisting liver transplant candidates: a pilot feasibility study. Alcohol Clin Exp Res. 2018;42:761.PubMedCrossRefGoogle Scholar
  112. 112.
    Chisholm-Burns MA, Spivey CA, Sredzinski E, Butler SL. Intervention toolbox to promote immunosuppressant therapy adherence in adult renal transplant recipients. J Am Pharm Assoc. 2012;52(6):816–22.CrossRefGoogle Scholar
  113. 113.
    Rodrigue JR, Mandelbrot DA, Pavlakis M. A psychological intervention to improve quality of life and reduce psychological distress in adults awaiting kidney transplantation. Nephrol Dial Transplant. 2011;26(2):709–15.PubMedCrossRefGoogle Scholar
  114. 114.
    Baines LS, Joseph JT, Jindal RM. Prospective randomized study of individual and group psychotherapy versus controls in recipients of renal transplants. Kidney Int. 2004;65(5):1937–42.CrossRefGoogle Scholar
  115. 115.
    Baines LS, Joseph JT, Jindal RM. Emotional issues after kidney transplantation: a prospective psychotherapeutic study. Clin Transpl. 2002;16(6):455–60.CrossRefGoogle Scholar
  116. 116.
    Policies. Organ Procurement and Transplantation Network. US Department of Health and Human Services [cited 2018 04/03]. Available from: https://optn.transplant.hrsa.gov/media/1200/optn_policies.pdf#nameddest=Policy_14
  117. 117.
    Janki S, Dor FJ, JN IJ. Surgical aspects of live kidney donation: an updated review. Front Biosci (Elite Ed). 2015;7:346–65.Google Scholar
  118. 118.
    Schold JD, Goldfarb DA, Buccini LD, Rodrigue JR, Mandelbrot DA, Heaphy EL, et al. Comorbidity burden and perioperative complications for living kidney donors in the United States. Clin J Am Soc Nephrol. 2013;8(10):1773–82.PubMedPubMedCentralCrossRefGoogle Scholar
  119. 119.
    Segev DL, Muzaale AD, Caffo BS, Mehta SH, Singer AL, Taranto SE, et al. Perioperative mortality and long-term survival following live kidney donation. JAMA. 2010;303(10):959–66.PubMedCrossRefGoogle Scholar
  120. 120.
    Choi SS, Cho SS, Ha TY, Hwang S, Lee SG, Kim YK. Intraoperative factors associated with delayed recovery of liver function after hepatectomy: analysis of 1969 living donors. Acta Anaesthesiol Scand. 2016;60(2):193–202.PubMedCrossRefGoogle Scholar
  121. 121.
    Gibney EM, Parikh CR, Garg AX. Age, gender, race, and associations with kidney failure following living kidney donation. Transplant Proc. 2008;40(5):1337–40.PubMedCrossRefGoogle Scholar
  122. 122.
    Lam NN, Schnitzler MA, Segev DL, Hess GP, Kasiske BL, Randall HB, et al. Diabetes mellitus in living pancreas donors: use of integrated National Registry and pharmacy claims data to characterize donation-related health outcomes. Transplantation. 2016;101(6):1276–81.CrossRefGoogle Scholar
  123. 123.
    Lentine KL, Lam NN, Axelrod D, Schnitzler MA, Garg AX, Xiao H, et al. Perioperative complications after living kidney donation: a national study. Am J Transplant. 2016;16(6):1848–57.PubMedCrossRefGoogle Scholar
  124. 124.
    Mandell MS, Smith AR, Dew MA, Gordon DB, Holtzman S, Howell T, et al. Early postoperative pain and its predictors in the adult to adult living donor liver transplantation cohort study. Transplantation. 2016;100(11):2362–71.PubMedPubMedCentralCrossRefGoogle Scholar
  125. 125.
    Dew MA, DiMartini AF, DeVito Dabbs AJ, Zuckoff A, Tan HP, McNulty ML, et al. Preventive intervention for living donor psychosocial outcomes: feasibility and efficacy in a randomized controlled trial. Am J Transplant. 2013;13(10):2672–84.PubMedCrossRefGoogle Scholar
  126. 126.
    Iacoviello BM, Shenoy A, Hunt J, Filipovic-Jewell Z, Haydel B, LaPointe Rudow D. A prospective study of the reliability and validity of the live donor assessment tool. Psychosomatics. 2017;58(5):519–26.PubMedCrossRefGoogle Scholar
  127. 127.
    DiMartini A, Crone C, Fireman M, Dew MA. Psychiatric aspects of organ transplantation in critical care. Crit Care Clin. 2008;24(4):949–81, xPubMedPubMedCentralCrossRefGoogle Scholar
  128. 128.
    Holtzman S, Clarke HA, McCluskey SA, Turcotte K, Grant D, Katz J. Acute and chronic postsurgical pain after living liver donation: incidence and predictors. Liver Transpl. 2014;20(11):1336–46.PubMedCrossRefGoogle Scholar
  129. 129.
    Bucak N, Begec Z, Erdil F, Toprak HI, Cumurcu BE, Demirtas Y, et al. Postoperative cognitive dysfunction in living liver transplant donors. Exp Clin Transplant. 2014;12(Suppl 1):81–5.PubMedGoogle Scholar
  130. 130.
    Agerskov H, Ludvigsen MS, Bistrup C, Pedersen BD. From donation to everyday life: living kidney donors’ experiences three months after donation. J Ren Care. 2016;42(1):43–52.PubMedCrossRefGoogle Scholar
  131. 131.
    Heldt J, Torrey R, Han D, Baron P, Tenggardjaja C, McLarty J, et al. Donor smoking negatively affects donor and recipient renal function following living donor nephrectomy. Adv Urol. 2011;2011:929263.PubMedPubMedCentralCrossRefGoogle Scholar
  132. 132.
    Lentine KL, Schnitzler MA, Xiao H, Axelrod D, Davis CL, McCabe M, et al. Depression diagnoses after living kidney donation: linking U.S. registry data and administrative claims. Transplantation. 2012;94(1):77–83.PubMedPubMedCentralCrossRefGoogle Scholar
  133. 133.
    Timmerman L, Laging M, Timman R, Zuidema WC, Beck DK, IJzermans JN, et al. The impact of the donors’ and recipients’ medical complications on living kidney donors’ mental health. Transpl Int. 2016;29(5):589–602.PubMedCrossRefGoogle Scholar
  134. 134.
    Kimura H, Onishi Y, Sunada S, Kishi S, Suzuki N, Tsuboi C, et al. Postoperative psychiatric complications in living liver donors. Transplant Proc. 2015;47(6):1860–5.PubMedCrossRefGoogle Scholar
  135. 135.
    Timmerman L, Timman R, Laging M, Zuidema WC, Beck DK, IJzermans JN, et al. Predicting mental health after living kidney donation: the importance of psychological factors. Br J Health Psychol. 2016;21(3):533–54.PubMedCrossRefGoogle Scholar
  136. 136.
    Ferrando SJ, Levenson JL, Owen JA. Clinical manual of psychopharmacology in the medically ill. Washington, DC: American Psychiatric Publishing, Inc; 2010.Google Scholar
  137. 137.
    Butt Z, Dew MA, Liu Q, Simpson MA, Smith AR, Zee J, et al. Psychological outcomes of living liver donors from a multi-center, prospective study: results from the Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL). Am J Transplant. 2016;17(5):1267–77.CrossRefGoogle Scholar
  138. 138.
    Parikh ND, Ladner D, Abecassis M, Butt Z. Quality of life for donors after living donor liver transplantation: a review of the literature. Liver Transpl. 2010;16(12):1352–8.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Psychiatry and Surgery (Transplant)Yale University School of Medicine, Yale UniversityNew HavenUSA
  2. 2.Department of PsychiatryYale UniversityNew HavenUSA

Personalised recommendations